Jubilant Pharmova Limited
Government Pension Fund Global (Norway) cut its stake in Jubilant Pharmova from 3.17% to 2.81%, selling 5,60,999 shares.
An integrated global pharmaceuticals company, Jubilant Pharmova operates across three core business segments: pharmaceuticals, contract research and development services, and proprietary novel drugs. The company serves domestic and international markets through its diversified portfolio and specialized capabilities in drug development and manufacturing. It combines vertically integrated operations with expertise in custom synthesis and advanced pharmaceutical formulations to address healthcare needs across multiple therapeutic areas.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.